Expert consensus statement on the use of stem cells for decompensated liver cirrhosis: a report from Stem Cell Engineering Group of Chinese Medical Association Medical Engineering Branch (2021)

doi:10.3877/cma.j.issn.2095-1221.2021.02.001

Abstract

Stem Cell Engineering Group of Chinese Medical Association Medical Engineering Branch. Expert consensus statement on the use of stem cells for decompensated liver cirrhosis: a report from Stem Cell Engineering Group of Chinese Medical Association Medical Engineering Branch (2021)[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2021, 11(02): 65-74.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxbygxbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-1221.2021.02.001

https://zhxbygxbzz.cma-cmc.com.cn/EN/Y2021/V11/I02/65

References 164

78	赵文静，张淑芹，刘淑荣, 等. 自体骨髓干细胞移植治疗终末期肝病56例临床观察[J]. 中西医结合肝病杂志, 2014, 24(1):9-12,67.
79	郑盛，杨涓，刘琼, 等. 经肝固有动脉自体骨髓间充质干细胞移植治疗失代偿期肝硬化的疗效及安全性[J]. 肝脏, 2016, 21(2):95-99.
80	Sun A, Gao W, Xiao T. Autologous bone marrow stem cell transplantation via the hepatic artery for the treatment of hepatitis B virus-related cirrhosis: a PRISMA-compliant meta-analysis based on the Chinese population[J]. Stem Cell Res Ther, 2020, 11(1):104.
81	Ma XR, Tang YL, Xuan M, et al. Transplantation of autologous mesenchymal stem cells for end-stage liver cirrhosis: a meta-analysis based on seven controlled trials[J]. Gastroenterol Res Pract, 2015:908275.
82	Bihari C, Anand L, Rooge S, et al. Bone marrow stem cells and their niche components are adversely affected in advanced cirrhosis of the liver[J]. Hepatology, 2016, 64(4):1273-1288.
83	Lim YL, Eom YW, Park SJ, et al. Bone marrow-derived mesenchymal stem cells isolated from patients with cirrhosis and healthy volunteers show comparable characteristics[J]. Int J Stem Cells, 2020, 13(3):394-403.
84	Guo C, Guo G, Zhou X, et al. Long-term outcomes of autologous peripheral blood stem cell transplantation in patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2019, 17(6):1175-1182,e2.
85	Deng Q, Cai T, Zhang S, et al. Autologous peripheral blood stem cell transplantation improves portal hemodynamics in patients with hepatitis B virus-related decompensated cirrhosis[J]. Hepat Mon, 2015, 15(12):e32498.
86	Yan L, Han Y, Wang J, et al. Peripheral blood monocytes from patients with HBV related decompensated liver cirrhosis can differentiate into functional hepatocytes[J]. Am J Hematol, 2007, 82(11):949-954.
87	曹秀梅，黄岂平，陈帅帅. 不同硬度基底上骨髓间充质干细胞与肝细胞,肝星状细胞的相互作用[J]. 中华肝脏病杂志, 2019, 27(6):424-429.
88	邓勤智，蔡挺，张顺, 等. 自体外周血干细胞移植对乙型肝炎肝硬化失代偿期患者肝脏声脉冲辐射力成像的影响[J]. 中华肝脏病杂志, 2015, 23(11):832-836.
89	李梅，党双锁，田长印, 等. 自体外周血干细胞移植治疗失代偿期肝硬化[J]. 肝脏, 2015, 20(4):269-272.
90	骆乐，薛华，罗兰云, 等. 自体外周血CD34⁺造血干细胞移植治疗晚期肝硬化的远期疗效[J]. 中华消化外科杂志, 2016, 15(7):709-714.
91	徐菁，张志勇. 自体外周血干细胞移植治疗乙型肝炎肝硬化临床观察[J]. 检验医学与临床, 2014, 11(10):1349-1350.
92	姚豫桐，罗兰云，薛华, 等. 自体外周血CD34⁺干细胞移植治疗晚期肝硬化100例的临床疗效分析[J]. 中华肝脏病杂志, 2014, 22(9):667-670.
93	张行芬，邓勤智，周文红, 等. 自体外周血造血干细胞移植治疗失代偿期乙型肝炎肝硬化患者三年疗效和安全性观察[J]. 中华临床感染病杂志, 2017, 10(2):119-124.
94	赵世民，郑林华，韩英, 等. 经由肝动脉输注自体外周血干细胞移植治疗终末期肝病的临床疗效[J]. 河北医学, 2016, 22(9):1411-1414.
1	中华医学会肝病学分会. 肝硬化腹水及其相关并发症的诊疗指南[J]. 临床肝胆病杂志, 2017, 33(10):1847-1863.
2	Sarin SK, Kumar M, Eslam M, et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission[J]. Lancet Gastroenterol Hepatol, 2020, 5(2):167-228.
3	中华医学会感染病学分会，中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12):2648-2669.
4	中华医学会感染病学分会，中华医学会肝病学分会. 丙型肝炎防治指南(2019版)[J]. 临床肝胆病杂志, 2019, 35(12):2670-2687.
5	Xiao J, Wang F, Wong NK, et al. Global liver disease burdens and research trends: Analysis from a Chinese perspective[J]. J Hepatol, 2019, 71(1):212-221.
6	D'Amico G, Morabito A, D'Amico M, et al. Clinical states of cirrhosis and competing risks[J]. J Hepatol, 2018, 68(3):563-576.
7	GBD 2017 Cirrhosis Collaborators. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet Gastroenterol Hepatol, 2020, 5(3):245-266.
8	国家卫生健康委员会. 中国卫生健康统计年鉴(2019年)[M].中国协和医科大学出版社，2019.
9	am Esch JS 2nd, Knoefel WT, Klein M, et al. Portal application of autologous CD133⁺ bone marrow cells to the liver: a novel concept to support hepatic regeneration[J]. Stem Cells, 2005, 23(4):463-470.
10	国家药品监督管理局药品审评中心, 人源性干细胞及其衍生细胞治疗产品临床试验技术指导原则(征求意见稿)(2020)[EB/OL]. URL
11	国家卫生计生委、国家食品药品监管总局, 干细胞临床研究管理办法(试行)[EB/OL]. URL
12	国家卫生计生委、国家食品药品监管总局. 干细胞制剂质量控制及临床前研究指导原则(试行) (2015)[EB/OL]. URL
13	国家卫生计生委、国家食品药品监管总局. 关于开展干细胞临床研究机构备案工作的通知(2015). URL
14	Han Y, Yan L, Han G, et al. Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy[J]. Cytotherapy, 2008, 10(4):390-396.
15	Nikeghbalian S, Pournasr B, Aghdami N, et al. Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis[J]. Arch Iran Med, 2011, 14(1):12-17.
16	Mohamadnejad M, Alimoghaddam K, Bagheri M, et al. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis[J]. Liver Int, 2013, 33(10):1490-1496.
17	Spahr L, Chalandon Y, Terraz S, et al. Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial[J]. PLoS One, 2013, 8(1):e53719.
95	赵文轩，张瑞娟，刘海玲, 等. 自体外周血干细胞移植治疗乙型肝炎肝硬化失代偿期38例[J]. 陕西医学杂志, 2014, 33(7):790-792.
96	郑晓燕，冯金鸽，杨秋凤, 等. 外周血干细胞经肝动脉介入移植技术治疗终末期肝病临床护理[J]. 陕西医学杂志, 2015, 44(3):382-382.
97	王禅，秦伟，戴勇, 等. 自体外周血干细胞移植治疗乙型肝炎肝硬化患者临床疗效及其对外周血T淋巴细胞亚群的影响[J]. 实用肝脏病杂志, 2019, 22(1):97-100.
98	赵芳芳，翟永贞，冯国和. 自体外周血干细胞移植治疗乙型肝炎肝硬化患者疗效及安全性分析[J]. 实用肝脏病杂志, 2019, 22(5):700-703.
99	Seki A, Sakai Y, Komura T, et al. Adipose tissue-derived stem cells as a regenerative therapy for a mouse steatohepatitis-induced cirrhosis model[J]. Hepatology, 2013, 58(3):1133-1142.
100	蔡峻岭，李卫国，王合群, 等. 脐血干细胞治疗失代偿期乙肝肝硬化的疗效[J]. 医药论坛杂志, 2014, 35(10):88-89.
101	董媛，师贞宗. 脐血干细胞移植对失代偿期肝硬化患者TNF-α浓度和CD45RO+粒细胞表达的影响[J]. 中华细胞与干细胞杂志（电子版）, 2017, 7(6):317-321.
102	公建庄，杜晨旭，陈雅宁, 等. 脐血间充质干细胞移植治疗失代偿期肝硬化的临床疗效观察[J]. 中国全科医学, 2014, 17(20):2392-2395.
103	江必武，贾学平，时昭红, 等. 脐血干细胞移植治疗失代偿期肝硬化后血常规及凝血功能的临床观察[J]. 血栓与止血学, 2014, 20(4):173-175,181.
104	江必武，贾学平，吴玉芳, 等. 脐血干细胞移植治疗对失代偿期肝硬化患者细胞因子水平的影响及其临床意义[J]. 华中科技大学学报（医学版）, 2015, 44(3):294-297.
105	焦栓林，赵晓蕊，张玉华, 等. 脐血干细胞联合小剂量生长抑素治疗乙型肝炎失代偿期肝硬化顽固性腹水的疗效观察[J]. 肝脏, 2018, 23(8):681-683.
106	李浩，周翔天，殷俊, 等. 人脐血干细胞移植术治疗肝炎后肝硬化的临床应用与观察[J]. 安徽医药, 2014, 18(7):1246-1249.
107	梁丽，顾福嘉，黄国美, 等. 脐血干细胞移植治疗失代偿期肝硬化效果观察[J]. 郑州大学学报（医学版）, 2014, 49(4):552-555.
108	梁丽，顾福嘉，杨大平, 等. 负筛选混合法分离提纯脐血干细胞治疗失代偿期肝硬化中长期临床疗效研究[J]. 中国中西医结合消化杂志, 2017, 25(10):721-724,729.
109	谭建荣. 脐带血干细胞移植治疗失代偿期肝硬化临床分析[J]. 中国基层医药, 2014, 21(5):655-657.
110	王波，唐晓鹏. 脐血干细胞与骨髓干细胞联合移植治疗大鼠急性肝衰竭实验研究[J]. 实用肝脏病杂志, 2014, 17(1):58-62.
18	Li L, Yan Y, Jian Z, et al. Curative effect of combined lamivudine, adefovir dipivoxil, and stem cell transplantation on decompensated hepatitis B cirrhosis[J]. Genet Mol Res, 2014, 13(4):9336-9342.
19	Salama H, Zekri A, Medhat E, et al. Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease[J]. Stem Cell Res Ther, 2014, 5(3):70.
20	Xu L, Gong Y, Wang B, et al. Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells[J]. J Gastroenterol Hepatol, 2014, 29(8):1620-1628.
21	King A, Barton D, Beard HA, et al. REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133⁺ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial[J]. BMJ Open, 2015, 5(3):e007700.
22	Zekri AR, Salama H, Medhat E, et al. The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency[J]. Stem Cell Res Ther, 2015, 6(1):118.
23	Fang XQ, Zhang JF, Song HY, et al. [Effect of umbilical cord mesenchymal stem cell transplantation on immune function and prognosis of patients with decompensated hepatitis B cirrhosis][J]. Zhonghua Gan Zang Bing Za Zhi, 2016, 24(12):907-910.
24	Mohamadnejad M, Vosough M, Moossavi S, et al. Intraportal infusion of bone marrow mononuclear or CD133⁺ cells in patients with decompensated cirrhosis: A double-blind randomized controlled trial[J]. Stem Cells Transl Med, 2016, 5(1):87-94.
25	Suk KT, Yoon JH, Kim MY, et al. Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial[J]. Hepatology, 2016, 64(6):2185-2197.
26	Lanthier N, Lin-Marq N, Rubbia-Brandt L, et al. Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns?[J]. Stem Cell Res Ther, 2017, 8(1):88.
27	Yu SJ, Yoon JH, Kim W, et al. Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis[J]. Korean J Intern Med, 2017, 32(2):261-268.
28	Newsome PN, Fox R, King AL, et al. Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial[J]. Lancet Gastroenterol Hepatol, 2018, 3(1):25-36.
29	Ghavamzadeh A, Sotoudeh M, Hashemi Taheri AP, et al. Liver fibrosis alleviation after co-transplantation of hematopoietic stem cells with mesenchymal stem cells in patients with thalassemia major[J]. Ann Hematol, 2018, 97(2):327-334.
30	Vosough M, Moossavi S, Mardpour S, et al. Repeated intraportal injection of mesenchymal stem cells in combination with pioglitazone in patients with compensated cirrhosis: a clinical report of two cases[J]. Arch Iran Med, 2016, 19(2):131-136.
31	Liu B, Cheng M, Chen X, et al. Autologous bone marrow cell transplantation in the treatment of HIV patients with compensated cirrhosis[J]. Biosci Rep, 2020, 40(6):BSR20191316.
32	Cardinale V, Carpino G, Gentile R, et al. Transplantation of human fetal biliary tree stem/progenitor cells into two patients with advanced liver cirrhosis[J]. BMC Gastroenterol, 2014, 14:204.
33	Shevela EY, Starostina NM, Pal'tsev AI, et al. Efficiency of cell therapy in liver cirrhosis[J]. Bull Exp Biol Med, 2016, 160(4):542-547.
34	Esmaeilzadeh A, Ommati H, Kooshyar MM, et al. Autologous bone marrow stem cell transplantation in liver cirrhosis after correcting nutritional anomalies, a controlled clinical study[J]. Cell J, 2019, 21(3):268-273.
111	王可敬，罗晓红，孙厚坦, 等. 脐血干细胞移植对失代偿期肝硬化肝功能及血流动力学的影响[J]. 疑难病杂志, 2014, 13(11):1126-1129,1133.
112	王丽华，陈玉梅，李炳茂, 等. 脐带血干细胞对慢乙肝失代偿期肝硬化的临床疗效[J]. 中华细胞与干细胞杂志（电子版）, 2016, 6(5):292-296.
113	薛超，马文娜，孙庆文, 等. 脐带间充质干细胞治疗失代偿期肝硬化12例临床疗效观察[J]. 肝脏, 2020, 25(1):66-68.
114	张岁，佟立新，闫宝勇, 等. 人脐血干细胞经外周静脉移植治疗失代偿期肝硬化的临床研究[J]. 天津医药, 2016, 44(1):83-87.
115	张岁，闫宝勇，佟立新, 等. 脐血干细胞移植治疗乙型肝炎肝硬化的疗效[J]. 实用医学杂志, 2015, 31(19):3162-3165.
116	周诗君，叶英，李家斌. 脐血干细胞移植治疗失代偿期肝硬化的疗效及安全性评价[J]. 安徽医科大学学报, 2016, 51(7):1035-1038.
117	周晓玲，谢胜，陈峭, 等. 脐血干细胞移植结合补益肾气利湿法对ChildA,B级肝硬化患者免疫功能的影响[J]. 实用临床医药杂志, 2014, 18(19):38-40,44.
118	周晓玲，谢胜，陈峭, 等. 脐血干细胞移植结合补益肾气利湿法治疗ChildA,B级肝硬化的疗效及机制探讨[J]. 实用临床医药杂志, 2014, 18(17):25-28.
119	周新人，王方，云升皓, 等. 人脐带血干细胞治疗失代偿期酒精性肝硬化临床观察[J]. 实用肝脏病杂志, 2017, 20(2):232-233.
120	周新人，王方，云升皓, 等. 脐带血干细胞治疗失代偿期原发性胆汁性肝硬化疗效观察[J]. 实用肝脏病杂志, 2016, 19(2):219-220.
121	朱理辉，罗勇，张琍, 等. 人脐带血干细胞经外周静脉,肝动脉移植治疗失代偿期肝硬化的患者近期疗效观察[J]. 中国现代医学杂志, 2016, 26(2):47-50.
122	朱彦红，韩大正. 脐血干细胞移植治疗失代偿期肝硬化的早期临床疗效探讨[J]. 中国医师进修杂志, 2014, 37(22):15-17.
123	朱彦红，武利萍，韩大正. 人脐血干细胞治疗失代偿期肝硬化对血常规和凝血功能的影响及其临床意义[J]. 中国现代医学杂志, 2015, 25(11):33-37.
124	Wu QL, Liu XY, Nie DM, et al. Umbilical cord blood-derived mesenchymal stem cells ameliorate graft-versus-host disease following allogeneic hematopoietic stem cell transplantation through multiple immunoregulations[J]. J Huazhong Univ Sci Technolog Med Sci, 2015, 35(4):477-484.
125	Berglund S, Magalhaes I, Gaballa A, et al. Advances in umbilical cord blood cell therapy: the present and the future[J]. Expert Opin Biol Ther, 2017, 17(6):691-699.
126	Zhang Z, Lin H, Shi M, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients[J]. J Gastroenterol Hepatol, 2012, 27 Suppl 2:112-120.
35	Huang KC, Chuang MH, Lin ZS, et al. Transplantation with GXHPC1 for liver cirrhosis: phase 1 trial[J]. Cell Transplant, 2019, 28(1_suppl):100s-111s.
36	Kim JK, Kim SJ, Kim Y, et al. Long-term follow-up of patients after autologous bone marrow cell infusion for decompensated liver cirrhosis[J]. Cell Transplant, 2017, 26(6):1059-1066.
37	Guo C, Guo G, Zhou X, et al. Long-term outcomes of autologous peripheral blood stem cell transplantation in patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2019, 17(6):1175-1182.e2.
38	Huang M, Feng Z, Ji D, et al. Use of a transjugular intrahepatic portosystemic shunt combined with autologous bone marrow cell infusion in patients with decompensated liver cirrhosis: an exploratory study[J]. Cytotherapy, 2014, 16(11):1575-1583.
39	Andreone P, Catani L, Margini C, et al. Reinfusion of highly purified CD133⁺ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial[J]. Dig Liver Dis, 2015, 47(12):1059-1066.
40	Al Mahtab M, Mf Akbar S, Begum M, et al. Stem cell therapy for cirrhosis of liver in bangladesh: specific design compatible for developing country[J]. Euroasian J Hepatogastroenterol, 2018, 8(2):121-125.
41	Liang J, Zhang H, Zhao C, et al. Effects of allogeneic mesenchymal stem cell transplantation in the treatment of liver cirrhosis caused by autoimmune diseases[J]. Int J Rheum Dis, 2017, 20(9):1219-1226.
42	Al Tayeb H, El Dorry A, Amer N, et al. Autologous stem cells transplantation in egyptian patients with liver cirrhosis on top of hepatitis C virus[J]. Int J Stem Cells, 2015, 8(2):209-218.
43	Gupta H, Youn GS, Han SH, et al. Response-related factors of bone marrow-derived mesenchymal stem cells transplantation in patients with alcoholic cirrhosis[J]. J Clin Med, 2019, 8(6):862.
44	Lukashyk SP, Tsyrkunov VM, Isaykina YI, et al. Mesenchymal bone marrow-derived stem cells transplantation in patients with hcv related liver cirrhosis[J]. J Clin Transl Hepatol, 2014, 2(4):217-221.
45	Sharma M, Kulkarni A, Sasikala M, et al. Long-term outcome of autologous hematopoietic stem cell infusion in cirrhosis: waning effect over time[J]. J Clin Transl Hepatol, 2020, 8(4):385-390.
46	Fang X, Liu L, Dong J, et al. A study about immunomodulatory effect and efficacy and prognosis of human umbilical cord mesenchymal stem cells in patients with chronic hepatitis B-induced decompensated liver cirrhosis[J]. J Gastroenterol Hepatol, 2018, 33(4):774-780.
47	Nakamura T, Torimura T, Iwamoto H, et al. CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis[J]. J Gastroenterol Hepatol, 2014, 29(10):1830-1838.
48	Kim K, Shin IS, Bang HJ, et al. Can bone marrow-derived mesenchymal stem cells change liver volume?: A case report[J]. JGH Open, 2021, 5(2):320-323.
49	Rajaram R, Subramani B, Abdullah BJJ, et al. Mesenchymal stem cell therapy for advanced liver cirrhosis: A case report[J]. JGH Open, 2017, 1(4):153-155.
50	Jang YO, Kim YJ, Baik SK, et al. Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study[J]. Liver Int, 2014, 34(1):33-41.
127	曾芝雨，李东良，方坚, 等. 脐带间充质干细胞联合骨髓干细胞移植治疗失代偿期肝硬化:1年随访对照[J]. 中国组织工程研究, 2015, 19(10):1533-1538.
128	陈建华，胡祥. 重复测量分析脐带间充质干细胞移植治疗肝硬化的疗效[J]. 中国组织工程研究, 2015, 19(19):3027-3031.
129	邓福珠，毕晓云，何蓉, 等. 无血清培养的脐带间充质干细胞治疗乙型肝炎肝硬化的临床观察[J]. 组织工程与重建外科杂志, 2014, 10(3):141-144, 167.
130	方雪晴，张骏飞，宋海燕, 等. 脐带间充质干细胞移植对失代偿期乙型肝炎肝硬化患者免疫功能和转归的影响[J]. 中华肝脏病杂志, 2016, 24(12):907-910.
131	方雪晴，张骏飞，宋海燕, 等. 人脐带间充质干细胞治疗后失代偿期乙型肝炎肝硬化患者的免疫功能和预后[J]. 中国组织工程研究, 2017, 21(17):2696-2701.
132	傅青春，姜舒，王晓今, 等. 人脐带间充质干细胞剂量递增静脉输注治疗失代偿性肝硬化的安全性研究[J]. 肝脏, 2014, 19(1):3-7.
133	傅青春，金银鹏，王晓今, 等. 移植人脐带干细胞改善乙型肝炎失代偿肝硬化患者的肝功能[J]. 中国组织工程研究, 2018, 22(25):3993-4000.
134	江小柯，李修岭，白阳秋, 等. 脐带间充质干细胞治疗慢乙肝肝硬化长期疗效分析[J]. 医药论坛杂志, 2018, 39(2):30-34.
135	柯昌征，刘莉，李东, 等. 人脐血间充质干细胞静脉移植治疗失代偿期肝硬化的疗效观察[J]. 浙江临床医学, 2014, (8):1185-1187.
136	李元元，徐若男，施明, 等. 人脐带间充质干细胞治疗慢加急性肝衰竭患者的初步临床观察[J]. 中华细胞与干细胞杂志(电子版), 2015, 5(1):36-40.
137	罗桂金，雷平光. 人脐带间充质干细胞辅助治疗对乙肝肝硬化患者肝功能,纤维化指标及炎症程度的影响[J]. 海南医学院学报, 2016, 22(11):1069-1072.
138	骆海飞，杨小安，张卡, 等. 人脐带间充质干细胞治疗乙肝肝硬化失代偿期疗效观察[J]. 中华实验和临床病毒学杂志, 2015, 29(3):239-241.
139	牛艳君，李莹，白仲添, 等. 脐带间充质干细胞移植术治疗肝硬化的临床疗效系统评价[J]. 肝胆胰外科杂志, 2015, 27(6):485-489.
140	任浩，董静，刘力伟, 等. 人脐带间充质干细胞治疗乙型肝炎肝硬化患者发生肝细胞癌的危险因素分析[J]. 中国组织工程研究, 2018, 22(9):1350-1356.
141	孙慧聪，张国尊，郭金波, 等. 脐带源间充质干细胞移植治疗肝纤维化及肝硬化的相关机制[J]. 中国组织工程研究, 2015, 19(41):6638-6645.
142	吴正敏，施小华，罗芳, 等. 经外周静脉输注移植人脐带间充质干细胞治疗失代偿期肝硬化的护理体会[J]. 山西医药杂志, 2015, 44(19):2318-2319.
51	Mu K, Zhang J, Gu Y, et al. Cord-derived mesenchymal stem cells therapy for liver cirrhosis in children with refractory Henoch-Schonlein purpura: A case report[J]. Medicine (Baltimore), 2018, 97(47):e13287.
52	Sakai Y, Takamura M, Seki A, et al. Phase I clinical study of liver regenerative therapy for cirrhosis by intrahepatic arterial infusion of freshly isolated autologous adipose tissue-derived stromal/stem (regenerative) cell[J]. Regen Ther, 2017, 6:52-64.
53	Wehbe TW, Abi Chahine NH, Annous AA, et al. A case report of congenital glycogen storage liver cirrhosis treated with bone marrow derived stem cells[J]. Stem Cell Investig, 2017, 4:73.
54	Jia Y, Shu X, Yang X, et al. Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis[J]. Stem Cell Res Ther, 2020, 11(1):277.
55	Wang L, Han Q, Chen H, et al. Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis[J]. Stem Cells Dev, 2014, 23(20):2482-2489.
56	Xue HL, Zeng WZ, Wu XL, et al. Clinical therapeutic effects of human umbilical cord-derived mesenchymal stem cells transplantation in the treatment of end-stage liver disease[J]. Transplant Proc, 2015, 47(2):412-418.
57	Kantarcıoğlu M, Demirci H, Avcu F, et al. Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis[J]. Turk J Gastroenterol, 2015, 26(3):244-250.
58	Sharma M, Rao PN, Sasikala M, et al. Autologous mobilized peripheral blood CD34(+) cell infusion in non-viral decompensated liver cirrhosis[J]. World J Gastroenterol, 2015, 21(23):7264-7271.
59	Wang MF, Li YB, Gao XJ, et al. Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study[J]. World J Stem Cells, 2018, 10(10):138-145.
60	Deng QZ, Cai T, Zhang S, et al. [Effects of autologous peripheral stem cell transplantation on acoustic radiation force impulse in patients with HBV-related decompensated cirrhosis][J]. Zhonghua Gan Zang Bing Za Zhi, 2015, 23(11):832-836.
61	Yao Y, Luo L, Xue H, et al. [Autologous peripheral blood CD34⁺ stem cells transplanted into 100 patients with advanced cirrhosis][J]. Zhonghua Gan Zang Bing Za Zhi, 2014, 22(9):667-670.
62	Yu SJ, Chen LM, Lyu S, et al. [Safety and efficacy of human umbilical cord derived-mesenchymal stem cell transplantation for treating patients with HBV-related decompensated cirrhosis][J]. Zhonghua Gan Zang Bing Za Zhi, 2016, 24(1):51-55.
63	刘金霞，张耀臣，庞宇慧, 等. 乙型肝炎病毒表面抗原阳性的乙型肝炎病毒感染患者行异基因造血干细胞移植的疗效观察[J].临床内科杂志, 2020, 37(7):497-500.
64	曹会娟，张绍全，翁伟镇, 等. 自体骨髓干细胞治疗失代偿期乙型肝炎肝硬化患者疗效及长期安全性观察[J]. 中华传染病杂志, 2017, 35(12):719-724.
65	郝德彦，宋志，孟兴凯. 经肝动脉自体骨髓干细胞肝内移植治疗对失代偿期肝硬化临床效果,肝功能及凝血指标的影响[J]. 中国医药导报, 2018, 15(35):126-129.
66	焦栓林，赵晓蕊，欧阳洪, 等. 自体骨髓间充质干细胞联合促肝细胞生长素治疗失代偿期酒精性肝硬化疗效分析[J]. 实用肝脏病杂志, 2017, 20(6):773-774.
143	于双杰，陈黎明，吕飒, 等. 人脐带间充质干细胞治疗失代偿性乙型肝炎肝硬化的安全性与疗效[J]. 中华肝脏病杂志, 2016, 24(1):51-55.
144	张岁，贾蓓，郭翠敏, 等. 经外周静脉移植脐带间充质干细胞治疗乙型肝炎肝硬化的效果观察[J]. 河北医科大学学报, 2017, 38(3):270-273, 330.
145	赵宇，祝瑜，张代忠, 人脐带间充质干细胞肝内移植联合苦参素治疗失代偿期乙型肝炎肝硬化患者疗效与转归分析[J]. 实用肝脏病杂志, 2018, 21(3):360-363.
146	张金龙，项春生，刘芙蓉, 等. 宫内膜干细胞治疗失代偿期乙型肝炎肝硬化疗效的初步探讨[J]. 中国病原生物学杂志, 2014, 9(9):838-841.
147	张金龙，项春生，刘芙蓉, 等. 宫内膜干细胞治疗失代偿期肝硬化疗效观察[J]. 武警医学, 2014, 25(6):543-546.
148	Duan Y, Catana A, Meng Y, et al. Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo[J]. Stem Cells, 2007, 25(12):3058-3068.
149	Tolosa L, Caron J, Hannoun Z, et al. Transplantation of hESC-derived hepatocytes protects mice from liver injury[J]. Stem Cell Res Ther, 2015, 6:246.
150	Khan AA, Shaik MV, Parveen N, et al. Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis[J]. Cell Transplant, 2010, 19(4):409-418.
151	AdiwinataPawitan J. Exploring the most promising stem cell therapy in liver failure: a systematic review[J]. Stem Cells Int, 2019, 2019:2782548.
152	Zhao L, Chen S, Shi X, et al. A pooled analysis of mesenchymal stem cell-based therapy for liver disease[J]. Stem Cell Res Ther, 2018, 9(1):72.
153	Spada M, Porta F, Righi D, et al. Intrahepatic administration of human liver stem cells in infants with inherited neonatal-onset hyperammonemia: a phase I study[J]. Stem Cell Rev Rep, 2020, 16(1):186-197.
154	Amin MA, Sabry D, Rashed LA, et al. Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study[J]. Clin Transplant, 2013, 27(4):607-612.
155	El-Ansary, Sh M, Abdel-Aziz, et al. Phase I trial: mesenchymal stem cells transplantation in end stage liver disease[J]. J American Science, 2010, 6(12):135-144.
156	Amer ME, El-Sayed SZ, El-Kheir WA, et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells[J]. Eur J Gastroenterol Hepatol, 2011, 23(10):936-941.
157	Levicar N, Pai M, Habib NA, et al. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34⁺ cells in patients with chronic liver disease[J]. Cell Prolif, 2008, 41(Suppl 1):115-125.
158	Wu CX, Wang D, Cai Y, et al. Effect of autologous bone marrow stem cell therapy in patients with liver cirrhosis: a meta-analysis[J]. J Clin Transl Hepatol, 2019, 7(3):238-248.
67	彭蕾，汤磊，叶珺, 等. 自体骨髓间充质干细胞移植治疗失代偿期肝硬化的疗效[J]. 中国肝脏病杂志(电子版), 2017, 9(1):83-86.
68	王方，云升皓，寇俊峰, 等. 两种类型的干细胞经门静脉注入治疗失代偿期肝硬化患者近期疗效观察[J]. 中国肝脏病杂志(电子版), 2014, 6(3):31-34.
69	王方，云升皓，周新人, 等. 经肝动脉自体骨髓或脐带血干细胞移植治疗失代偿期肝硬化患者的安全性和近期疗效比较[J]. 实用肝脏病杂志, 2014, 17(4):356-359.
70	王海舫，刘洪霞，邵菲, 等. 经肝动脉途径兔自体骨髓干细胞移植治疗肝硬化[J]. 中国组织工程研究, 2016, 20(36):5392-5397.
71	王振常，黄贵华，黄晶晶, 等. 纯化自体骨髓干细胞经肝动脉移植治疗失代偿期肝硬化的疗效及安全性分析[J]. 胃肠病学和肝病学杂志, 2014, 23(5):497-500.
72	王震凯，魏娟，吴琳, 等. 自体骨髓干细胞对肝硬化患者外周血淋巴细胞和免疫球蛋白的影响[J]. 中华细胞与干细胞杂志(电子版), 2015, 5(1):13-18.
73	王震凯，吴琳，魏娟, 等. 自体骨髓间充质干细胞移植治疗难治性肝硬化腹水患者的临床疗效观察[J]. 中华细胞与干细胞杂志(电子版), 2014, 4(4):227-231.
74	吴锋，蒲春文，张勇. 自体骨髓间充质干细胞移植治疗失代偿期肝硬化的临床疗效观察[J]. 中国肝脏病杂志(电子版), 2015, 7(3):130-134.
75	吴玉卓，杨乐，翟玉峰, 等. 自体骨髓间充质干细胞治疗乙型肝炎失代偿期患者:肝纤维化,肝功能, MELD评分及1年生存率分析[J]. 中国组织工程研究, 2017, 21(13):2049-2055.
76	闫焕杰，张淑芹，赵文静. 自体骨髓干细胞移植治疗慢加急性乙型肝炎肝衰竭患者疗效初步研究[J]. 实用肝脏病杂志, 2019, 22(1):81-84.
77	张超，李宏宇，郭晓钟, 等. 自体骨髓干细胞移植治疗失代偿期肝硬化的临床效果分析[J]. 现代生物医学进展, 2015, 15(10):1873-1876.
159	Sang W, Lv B, Li K, et al. Therapeutic efficacy and safety of umbilical cord mesenchymal stem cell transplantation for liver cirrhosis in Chinese population: A meta-analysis[J]. Clin Res Hepatol Gastroenterol, 2018, 42(3):193-204.
160	Ma YC, Yang JY, Yan LN. Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta- analysis[J]. Eur J Gastroenterol Hepatol, 2013, 25(9):1007-1016.
161	Zhong C, Wu JD, Fang MM, et al. Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis[J]. Tumour Biol, 2015, 36(10):7623-7630.
162	Qi X, Guo X, Su C. Clinical outcomes of the transplantation of stem cells from various human tissue sources in the management of liver cirrhosis: a systematic review and meta-analysis[J]. Curr Stem Cell Res Ther, 2015, 10(2):166-180.
163	Pan XN, Zheng LQ, Lai XH. Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: a meta-analysis[J]. World J Gastroenterol, 2014, 20(38):14051-14057.
164	Chen B, Pang L, Cao H, et al. Autologous stem cell transplantation for patients with viral hepatitis-induced liver cirrhosis: a systematic review and meta-analysis[J]. Eur J Gastroenterol Hepatol, 2019, 31(10):1283-1291.

Please choose a citation manager

Content to export

Expert consensus statement on the use of stem cells for decompensated liver cirrhosis: a report from Stem Cell Engineering Group of Chinese Medical Association Medical Engineering Branch (2021)

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

References 164

Related Articles 0

Recommended Articles

Metrics

Comments

模态框（Modal）标题

Please choose a citation manager

Content to export

Expert consensus statement on the use of stem cells for decompensated liver cirrhosis: a report from Stem Cell Engineering Group of Chinese Medical Association Medical Engineering Branch (2021)

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

References 164

Related Articles 0

Recommended Articles

Metrics

Comments